As a part of Pfizer and backed by its expert resources, our collaborative approach means we can explore more efficient routes to market and high-quality sterile injectables manufacturing.
You can count on us to do our best to carefully guide your compound from development through to commercial manufacture - we’ve been delivering on our promises for over 40 years.
We’re part of Pfizer, so you’ll be supported by our team and backed by the tools, processes and experience of one of the world’s leading sterile injectables manufacturers.
With its own portfolio of biopharmaceuticals and injectables, Pfizer continually invests in our manufacturing sites to maintain them at the cutting edge of technology.
Our regulatory knowledge spans across the globe and we have established regulatory approvals in multiple markets including the U.S. FDA (United States), EMA (European Union), ANVISA (Brazil) and PMDA (Japan).
We have manufacturing capabilities in Biologics, Small molecules, Cytotoxics (liquid), and Lyophilization.
There are many complexities facing lyophilized product development and manufacturing. Using our extensive experience, we can optimize and scale-up your lyophilization process to match the needs of your unique compound at commercial scale.
By carefully considering your drug’s formulation, attributes and our lyophilization capabilities, our team of experts ensure proper cycle design every time.
Manufacturing network includes: